Yajuan Cui

605 total citations
25 papers, 356 citations indexed

About

Yajuan Cui is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Yajuan Cui has authored 25 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Yajuan Cui's work include Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Salivary Gland Tumors Diagnosis and Treatment (4 papers). Yajuan Cui is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Salivary Gland Tumors Diagnosis and Treatment (4 papers). Yajuan Cui collaborates with scholars based in China, United States and United Kingdom. Yajuan Cui's co-authors include Hongling Peng, Tiejun Qin, Zefeng Xu, Zhijian Xiao, Yu Zhu, Robert Peter Gale, Jing Liu, Heng Li, Pan Wang and Yanan Li and has published in prestigious journals such as Blood, The American Journal of Surgical Pathology and Journal of Cellular Physiology.

In The Last Decade

Yajuan Cui

24 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yajuan Cui China 10 186 119 95 63 50 25 356
Julien Broséus France 9 116 0.6× 136 1.1× 152 1.6× 25 0.4× 32 0.6× 23 300
Alexis Caulier France 9 164 0.9× 87 0.7× 87 0.9× 74 1.2× 130 2.6× 24 311
Sophie Kaltenbach France 10 237 1.3× 99 0.8× 75 0.8× 44 0.7× 52 1.0× 21 421
Abd Aziz Ibrahim Japan 8 172 0.9× 162 1.4× 71 0.7× 22 0.3× 35 0.7× 12 397
Matthew Decker United States 7 114 0.6× 164 1.4× 121 1.3× 35 0.6× 25 0.5× 9 299
Samaneh Farashi Iran 9 149 0.8× 200 1.7× 244 2.6× 42 0.7× 49 1.0× 31 452
Nicholas Williams United Kingdom 8 169 0.9× 175 1.5× 138 1.5× 12 0.2× 45 0.9× 16 430
Cassandra P. Loren United States 7 111 0.6× 196 1.6× 96 1.0× 36 0.6× 16 0.3× 8 342
Serena Martinelli Italy 12 176 0.9× 125 1.1× 176 1.9× 19 0.3× 15 0.3× 32 400
Meira Zoldan Israel 8 53 0.3× 154 1.3× 116 1.2× 80 1.3× 96 1.9× 9 306

Countries citing papers authored by Yajuan Cui

Since Specialization
Citations

This map shows the geographic impact of Yajuan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yajuan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yajuan Cui more than expected).

Fields of papers citing papers by Yajuan Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yajuan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yajuan Cui. The network helps show where Yajuan Cui may publish in the future.

Co-authorship network of co-authors of Yajuan Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yajuan Cui. A scholar is included among the top collaborators of Yajuan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yajuan Cui. Yajuan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Weijun, Die Xu, Xiaowei Wang, et al.. (2025). Identification of Bruceine A as a novel HSP90AB1 inhibitor for suppressing hepatocellular carcinoma growth. Journal of Advanced Research. 82. 863–879. 1 indexed citations
2.
Cui, Yajuan, Peilong Wang, Huifang Zhang, et al.. (2025). Single-Cell Transcriptomic Analysis of Myeloid Lineage Evolution from CD19 CAR-T Cell Therapy. Pathobiology. 92(3). 180–186.
3.
Cui, Yajuan, Ye Zhang, Yuping Liu, et al.. (2024). EN1 promotes lung metastasis of salivary adenoid cystic carcinoma by regulating the PI3K-AKT pathway and epithelial-mesenchymal transition. Cancer Cell International. 24(1). 51–51. 2 indexed citations
4.
Zhu, Lijing, Lisha Sun, Ye Zhang, et al.. (2024). PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma. The American Journal of Surgical Pathology. 48(6). 681–690. 2 indexed citations
5.
Zhang, Ye, Lijing Zhu, Zheng Zhou, et al.. (2023). Notch activation promotes bone metastasis via SPARC inhibition in adenoid cystic carcinoma. Oral Diseases. 30(3). 1220–1233. 2 indexed citations
6.
Zhu, Lijing, et al.. (2023). Familial gigantiform cementoma with recurrent ANO5 p.Cys356Tyr mutations: Clinicopathological and genetic study with literature review. Molecular Genetics & Genomic Medicine. 12(1). e2277–e2277. 2 indexed citations
7.
Zhang, Ye, Zheng Zhou, Xiaoxiao Liu, et al.. (2023). Colloid Pattern of Salivary Mucinous Adenocarcinomas With Recurrent BRAF V600E Mutations. The American Journal of Surgical Pathology. 48(3). 266–274. 2 indexed citations
8.
Cui, Yajuan. (2022). Relationship between Social Support and Life Satisfaction among College Students: The Mediation of Hope. International Journal of Learning and Teaching. 59–63. 1 indexed citations
9.
Li, Yanan, Pan Wang, Yu Zhu, et al.. (2021). The emerging role of ISWI chromatin remodeling complexes in cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 346–346. 51 indexed citations
10.
He, Yanjuan, Duanfeng Jiang, Yinghong Zhu, et al.. (2021). Chidamide, a subtype-selective histone deacetylase inhibitor, enhances Bortezomib effects in multiple myeloma therapy. Journal of Cancer. 12(20). 6198–6208. 7 indexed citations
11.
Jiang, Duanfeng, Yinghong Zhu, Yan Zhu, et al.. (2021). Chidamide-Induced Accumulation of Reactive Oxygen Species Increases Lenalidomide Sensitivity Against Multiple Myeloma Cells. OncoTargets and Therapy. Volume 14. 4061–4075. 4 indexed citations
12.
Cheng, Zhao, Ruijuan Li, Haiying Zhong, et al.. (2020). Targeting lactate dehydrogenase A ( LDHA ) exerts antileukemic effects on T‐cell acute lymphoblastic leukemia. Cancer Communications. 40(10). 501–517. 41 indexed citations
13.
Zhou, Qin, et al.. (2018). Bilateral adrenal hemorrhage revealed antiphospholipid syndrome in a male patient: benefit from comprehensive treatment. Current Medical Research and Opinion. 34(12). 2165–2168. 3 indexed citations
14.
Shi, Zhihong, et al.. (2017). Impulse oscillometry system as an alternative diagnostic method for chronic obstructive pulmonary disease. Medicine. 96(46). e8543–e8543. 53 indexed citations
15.
Cui, Yajuan, Hongyan Tong, Xin Du, et al.. (2016). TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia. PubMed. 3. 50–50. 9 indexed citations
16.
Cui, Yajuan, Hongyan Tong, Xin Du, et al.. (2015). Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia. Experimental Hematology and Oncology. 4(1). 14–14. 29 indexed citations
17.
Gale, Robert Peter, Wen Cui, Gang Huang, et al.. (2015). A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes. Experimental Hematology and Oncology. 5(1). 12–12. 18 indexed citations
18.
Wu, Xudong, Jesper Frank Christensen, K. Rasmussen, et al.. (2015). Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals. Cell Research. 25(11). 1205–1218. 37 indexed citations
19.
Li, Bing, Junqing Xu, Jingya Wang, et al.. (2014). Calreticulin mutations in Chinese with primary myelofibrosis. Haematologica. 99(11). 1697–1700. 34 indexed citations
20.
Cui, Yajuan, Bing Li, Robert Peter Gale, et al.. (2014). Molecular Aberrations of Chronic Neutrophilic Leukemia: The CSF3R and SETBP1 Mutations. Blood. 124(21). 5578–5578. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julien Broséus Breakdown of academic impact, for papers by Alexis Caulier Breakdown of academic impact, for papers by Sophie Kaltenbach Breakdown of academic impact, for papers by Abd Aziz Ibrahim Breakdown of academic impact, for papers by Matthew Decker Breakdown of academic impact, for papers by Samaneh Farashi Breakdown of academic impact, for papers by Nicholas Williams Breakdown of academic impact, for papers by Cassandra P. Loren Breakdown of academic impact, for papers by Serena Martinelli Breakdown of academic impact, for papers by Meira Zoldan
Rankless by CCL
2026